A randomized, double‐blind phase <scp>I</scp>/<scp>II</scp>a study of intranasal glutathione in <scp>P</scp>arkinson's disease

K. Mischley, Laurie; B. Leverenz, James; Lau, Richard; L. Polissar, Nayak; B. Neradilek, Moni; Samii, Ali; J. Standish, Leanna

doi:10.1002/mds.26351

Public

A randomized, double‐blind phase I/IIa study of intranasal glutathione in Parkinson's disease

Published in Movement Disorders • Jul 31, 2015

Authors:

Laurie K. Mischley

James B. Leverenz

Richard Lau

Abstract

BACKGROUND: Depletion of reduced glutathione is associated with PD and glutathione augmentation has been proposed as a disease-modifying strategy. The aim of this study was to determine the safety and tolerability of intranasal reduced glutathione in individuals with PD. METHODS: Thirty individuals ...

Subject

Tolerability

Medicine

Glutathione

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!